Duato Joaquin sells $32.2M of JNJDuato Joaquin 内部减持 强生 (JNJ) $32.2M
Sale Details
Johnson & Johnson (JNJ) CEO and Chairman Duato Joaquin completed an open-market sale of 123,291 company shares on August 13, 2026, for total proceeds of $32,199,927 at an average per-share price of $261.17. The transaction was filed with the U.S. Securities and Exchange Commission via a Form 4 on August 14, 2026, representing a mandatory disclosure of executive shareholding changes that provides market participants with public records of core management trading activity. Based on JNJ’s $627.4 billion current market capitalization, the sale value equals just 0.005% of total company value, classifying it as a small-scale transaction.
Transaction Signal Context
As JNJ’s highest-ranking executive and a board member, Duato Joaquin’s trading activity warrants cross-reference to recently filed public disclosures. Per available SEC Form 4 filings, he completed two additional open-market sales on August 14, 2026: 20,976 shares at $262 per share and 102,315 shares at $261 per share, combining for exactly 123,291 shares matching the total share count and proceeds of the disclosed transaction. He also executed two open-market sales totaling roughly 48,480 shares on August 7, 2026. The August 13 sale falls within the scope of his recent routine small-scale equity liquidations, with no deviation from his historical trading patterns.
Follow-up markers
This Form 4 filing only documents the actual completed open-market trade, and does not confirm the seller’s motivation, future company business outlook, or expected stock price performance. No inference can be made about whether the trade was executed under a pre-arranged 10b5-1 plan unless explicitly stated in the official filing. Further, the minimal size of the sale does not reflect broader executive sentiment about JNJ’s valuation.
本次减持详情
强生（JNJ）首席执行官兼董事长Duato Joaquin于2026年8月13日完成123,291股公司股票的公开市场出售，交易总价值32,199,927美元，对应每股均价261.17美元。该笔交易于2026年8月14日通过Form 4文件向美国SEC提交，属于强制披露的高管持股变动信息，为市场参与者提供了核心管理层的公开交易记录。以强生当前6274亿美元的市值计算，本次减持价值仅占总市值的0.005%，属于小额交易。
交易信号背景
作为强生最高级别高管兼董事会成员，Duato Joaquin的交易行为需结合近期公开披露的其他操作对照判断。根据SEC已提交的Form 4文件，其在2026年8月14日单日还完成了两笔额外的公开市场减持，分别出售20,976股（均价262美元）和102,315股（均价261美元），合计123,291股，总价值与本次披露的交易完全匹配。此外，其在8月7日也曾进行两笔公开市场减持，合计约4.85万股。本次减持属于其近期常规的小额持股套现操作，未超出历史交易规模范围。
后续关注
本次Form 4披露仅记录实际发生的场内交易，无法推断交易动机（如个人财务规划、税收安排等）、公司未来业务前景或股价表现。若文件未明确提及10b5-1预先交易计划，则无法确认该减持是否属于预设合规交易。同时，该减持占总市值比例极低，不代表公司整体管理层对企业估值的判断。
This analysis was generated by InvestLog AI based on SEC filings, Form 4 insider transactions, Form 144 planned-sale notices, 13F institutional holdings, analyst ratings, and market data. It is for informational purposes only and does not constitute investment advice.这篇研究由 InvestLog AI 基于 SEC 披露、Form 4 内部人交易、Form 144 计划减持、13F 机构持仓、分析师评级和市场数据生成。内容仅供参考，不构成投资建议。